Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Macrogol 4000 for children with functional abdominal pain
NL-OMON24535Not yet recruiting
- Sponsor
- HagaZiekenhuis
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in functional abdominal pain syndrome (CAPS) comparing Macrogol 4000 with Placebo (2 arms). Primary endpoint: Percentage of pain-free patients. Planned start Nov 2016; status: not yet recruiting.
02
Drugs
macrogol 4000
03
Conditions
functional abdominal pain syndrome (CAPS)
Beyond the preview
Go deeper on NL-OMON24535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24535.